Household carbon monoxide (CO) concentrations in a large African city: An unquantified public health burden?

Autor: Orina, F., Amukoye, E., Bowyer, C., Chakaya, J., Das, D., Devereux, G., Dobson, R., Dragosits, U., Gray, C., Kiplimo, R., Lesosky, M., Loh, M., Meme, H., Mortimer, K., Ndombi, A., Pearson, C., Price, H., Twigg, M., West, S., Semple, S.

Publikováno v: In Environmental Pollution 15 June 2024 351

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries

Autor: Stolbrink, M, Chinouya, MJ, Jayasooriya, S, Nightingale, R, Evans-Hill, L, Allan, K, Allen, H, Balen, J, Beacon, T, Bissell, K, Chakaya, J, Chiang, C-Y, Cohen, M, Devereux, G, El Sony, A, Halpin, DMG, Hurst, Kiprop, C, Lawson, A, Macé, C, Makhanu, A, Makokha, P, Masekela, R, Meme, H, Khoo, EM, Nantanda, R, Pasternak, S, Perrin, C, Reddel, H, Rylance, S, Schweikert, P, Were, C, Williams, S, Winders, T, Yorgancioglu, A, Marks, GB, Mortimer, K

Publikováno v: The International Journal of Tuberculosis and Lung Disease. 26:1023-1032

Funder: Medical Research Council
BACKGROUND: Access to affordable inhaled medicines for chronic respiratory diseases (CRDs) is severely limited in low- and middle-income countries (LMICs), causing avoidable morbidity and mortality. The Internati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12a5c158640723eb0bcd9faa4f5089a6
https://doi.org/10.5588/ijtld.22.0270

Clinical standards for the dosing and management of TB drugs

Autor: Alffenaar, J W C, Stocker, S L, Forsman, L Davies, Garcia-Prats, A, Heysell, S K, Aarnoutse, R E, Akkerman, O W, Aleksa, A, van Altena, R, de Oñata, W Arrazola, Bhavani, P K, Van't Boveneind-Vrubleuskaya, N, Carvalho, A C C, Centis, R, Chakaya, J M, Cirillo, D M, Cho, J G, D Ambrosio, L, Dalcolmo, M P, Denti, P, Dheda, K, Fox, G J, Hesseling, A C, Kim, H Y, Köser, C U, Marais, B J, Margineanu, I, Märtson, A G, Torrico, M Munoz, Nataprawira, H M, Ong, C W M, Otto-Knapp, R, Peloquin, C A, Silva, D R, Ruslami, R, Santoso, P, Savic, R M, Singla, R, Svensson, E M, Skrahina, A, van Soolingen, D, Srivastava, S, Tadolini, M, Tiberi, S, Thomas, T A, Udwadia, Z F, Vu, D H, Zhang, W, Mpagama, S G, Schön, T, Migliori, G B

Publikováno v: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, vol 26, iss 6
International Journal of Tuberculosis and Lung Disease, 26, 6, pp. 483-499
International Journal of Tuberculosis and Lung Disease, 26, 483-499
International Journal of Tuberculosis and Lung Disease, 26(6), 483-499. International Union against Tubercul. and Lung Dis.

BACKGROUND: Optimal drug dosing is important to ensure adequate response to treatment, prevent development of drug resistance and reduce drug toxicity. The aim of these clinical standards is to provide guidance on ‘best practice´ for dosing and ma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aef5c7cecf38f14102fd039dc3e030b
https://escholarship.org/uc/item/59969461

Over-prescription of short-acting β

Autor: Adel, Khattab, Ashraf, Madkour, Anish, Ambaram, Clifford, Smith, Chakaya J, Muhwa, Jared O, Mecha, Mohamed, Alsayed, Maarten J H I, Beekman

Publikováno v: Current medical research and opinion. 38(11)

The extent of short-acting βData on disease characteristics/asthma treatments were collected from patients (≥12 years) using electronic case report forms. Patients were classified by investigator-defined asthma severity (guided by the 2017 Global

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d70dc7b3f3e11a2cd36f42d99d0bca29
https://pubmed.ncbi.nlm.nih.gov/36031882